SAUNDERS BRENT L — SEC Form 4 filings

SEC reporting owner CIK 1268854. 20 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2024-03-01 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ARS Pharmaceuticals, Inc. (SPRY)Director41 leg · 120,000 sh · $1,710,0245
Bausch & Lomb Corp (BLCO)Chairman of the Board and CEO, Director133 legs · 68,950 sh · $1,005,09718
Beauty Health Co (SKIN)Director31 leg · 40,450 sh · $43,6867

Form 4 filings — SAUNDERS BRENT L

FiledFormIssuerReported transactionsSource
2026-08-074Bausch & Lomb Corp (BLCO)Tax withholding (F): 4,231 @ $16.76 · Grant/award (A): 281,879 @ $0EDGAR
2026-06-264ARS Pharmaceuticals, Inc. (SPRY)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2026-05-264Bausch & Lomb Corp (BLCO)Tax withholding (F): 2,886 @ $15.92EDGAR
2026-03-104Bausch & Lomb Corp (BLCO)Purchase (P): 14,700 @ $17.14 · Grant/award (A): 14,700 @ $0EDGAR
2026-03-024Bausch & Lomb Corp (BLCO)Tax withholding (F): 22,059 @ $18.49 · Tax withholding (F): 24,649 @ $18.30EDGAR
2026-02-274Bausch & Lomb Corp (BLCO)Grant/award (A): 327,102 @ $0EDGAR
2026-02-254Bausch & Lomb Corp (BLCO)Tax withholding (F): 65,444 @ $17.99EDGAR
2025-08-074Bausch & Lomb Corp (BLCO)Tax withholding (F): 4,231 @ $14.44EDGAR
2025-07-234Bausch & Lomb Corp (BLCO)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2025-06-274ARS Pharmaceuticals, Inc. (SPRY)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-184Beauty Health Co (SKIN)Grant/award (A): 73,051EDGAR
2025-05-274Bausch & Lomb Corp (BLCO)Purchase (P): 22,000 @ $11.28 · Grant/award (A): 22,000 @ $0EDGAR
2025-05-224ARS Pharmaceuticals, Inc. (SPRY)Option exercise (M): 120,000 @ $1.01 · Sale (S): 120,000 @ $14.25 · Option exercise (M): 120,000 (derivative) @ $0EDGAR
2025-02-284Bausch & Lomb Corp (BLCO)Grant/award (A): 168,168 @ $0 · Grant/award (A): 600,858 (derivative) @ $0EDGAR
2024-12-264Bausch & Lomb Corp (BLCO)Tax withholding (F): 73,782 @ $17.83 · Tax withholding (F): 24,649 @ $17.83EDGAR
2024-08-134Beauty Health Co (SKIN)Purchase (P): 40,450 @ $1.08EDGAR
2024-08-074Bausch & Lomb Corp (BLCO)Purchase (P): 32,250 @ $15.66 · Grant/award (A): 32,250 @ $0EDGAR
2024-07-104Beauty Health Co (SKIN)Tax withholding (F): 3,711 @ $16.88 · Tax withholding (F): 3,076 @ $12.86 · Tax withholding (F): 2,166 @ $11.79 · Tax withholding (F): 2,167 @ $9.10 · Tax withholding (F): 13,548 @ $12.90 · Grant/award (A): 78,534EDGAR
2024-06-244ARS Pharmaceuticals, Inc. (SPRY)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-03-014Bausch & Lomb Corp (BLCO)Grant/award (A): 187,919 @ $0 · Grant/award (A): 569,105 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1268854 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →